Structure-function relationships in the mineralocorticoid receptor

Journal of Molecular Endocrinology

Volumn 41, Issue 5-6, 2008, Pages 405-413

  Pippal, Jyotsna B ^a   Fuller, Peter J ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; GLUCOCORTICOID; HYDROCORTISONE; LIGAND; MINERALOCORTICOID RECEPTOR; TRANSCRIPTION FACTOR;

BINDING AFFINITY; ELECTROLYTE BALANCE; FLUID BALANCE; HEART FAILURE; HORMONE ACTION; HUMAN; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; STRUCTURE ACTIVITY RELATION; TISSUE SPECIFICITY;

ANIMALS; HUMANS; RECEPTORS, MINERALOCORTICOID; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 57749102487     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/JME-08-0093     Document Type: Review

References (84)

1. Agarwal MK & Mirshahi M 1999 General overview of mineralocorticoid hormone action. Pharmacology and Therapeutics 84 273-326.
2. Alland L, Muhle R, Hou H, Potes J Jr, Chin L & Schreiber-Agus N 1997 Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387 49-55.
3. Arai K, Tsigos C, Suzuki Y, Irony I, Karl M, Listwak S & Chrousos GP 1994 Physiological and molecular aspects of mineralocorticoid receptor action in pseudohypoaldosteronism: a responsiveness test and therapy. Journal of Clinical Endocrinology and Metabolism 79 1019-1023.
4. Arriza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE & Evans RM 1987 Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237 268-275.
5. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J & O'Malley BW 1988 Cloning and expression of full-length cDNA encoding human vitamin D receptor. PNAS 85 3294-3298.
6. Baker ME, Chandsawangbhuwana C & Ollikainen N 2007 Structural analysis of the evolution of steroid specificity in the mineralocorticoid and glucocorticoid receptors. BMC Evolutionary Biology 7 24.
7. Benbrook D & Pfahl M 1987 A novel thyroid hormone receptor encoded by a cDNA clone from a human testis library. Science 238 788-791.
8. Benbrook D, Lernhardt E & Pfahl M 1988 A new retinoic acid receptor identified from a hepatocellular carcinoma. Nature 333 669-672.
9. Bledsoe RK, Montana VG, Stanley TB, Delves CJ, Apolito CJ, McKee DD, Consler TG, Parks DJ, Stewart EL, Willson TM et al. 2002 Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell 110 93-105.
10. Bledsoe RK, Madauss KP, Holt JA, Apolito CJ, Lambert MH, Pearce RH, Stanley TB, Stewart EL, Trump RP & Willson TM 2005 A ligand mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. Journal of Biological Chemistry 280 31283-31293.
11. De Bosscher K, Vanden Berghe W & Haegeman G 2003 The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. Endocrine Reviews 24 488-522.
12. Cachofeiro V, Miana M, de Las Heras N, Martín-Fernández B, Ballesteros S, Fernández-Tresguerres J & Lahera V 2008 Aldosterone and the vascular system. Journal of Steroid Biochemistry and Molecular Biology 109 331-335.
13. Connell JMC, MacKenzie SM, Marie Freel E, Fraser R & Davies E 2008 A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function. Endocrine Reviews 29 133-154.
14. DeRijk RH, Wust S, Meijer OC, Zennaro MC, Federenko IS, Hellhammer DH, Giacchetti G, Vreugdenhil E, Zitman F & de Koet KR 2006 A common polymorphism in the mineralocorticoid receptor modulates stress responsiveness. Journal of Clinical Endocrinology and Metabolism 91 5083-5089.
15. Fagart J, Huyet J, Pinon GM, Rochel M, Mayer C & Rafestin-Oblin ME 2005 Cystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nature Structural and Molecular Biology 12 554-555.
16. Fan YS, Eddy RL & Byers MG 1989 The human mineralocorticoid receptor gene (MLR) is located on chromosome 4 at q31.2. Cytogenetics and Cell Genetics 52 83-84.
17. Farman N & Rafestin-Oblin ME 2001 Multiple aspects of mineralocorticoid selectivity. American Journal of Physiology. Renal Physiology 280 F181-F192.
18. Ferrari P, Lovati F & Frey FJ 2000 The role of the 11beta-hydroxysteroid dehydrogenase type 2 in human hypertension. Journal of Hypertension 18 241-248.
19. Fuller PJ & Young MJ 2005 Mechanisms of mineralocorticoid action. Hypertension 46 1227-1235.
20. Fuller PJ, Smith BJ & Rogerson FM 2004 Cortisol resistance in the New World revisited. Trends in Endocrinology and Metabolism 15 296-299.
21. Funder JW 2006 Minireview: aldosterone and the cardiovascular system: genomic and nongenomic effects. Endocrinology 147 5564-5567.
22. Fuse H, Kitagawa H & Kato S 2000 Characterization of transactivational property and coactivator mediation of rat mineralocorticoid receptor activation function-1 (AF-1). Molecular Endocrinology 14 889-899.
23. Geller DS, Farhi A & Pinkerton N 2000 Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy. Science 289 119-123.
24. Glass CK & Rosenfeld MG 2000 The coregulator exchange in transcriptional functions of nuclear receptors. Genes and Development 14 121-141.
25. Govindan MV & Warriar N 1998 Reconstitution of the N-terminal transcription activation function of human mineralocorticoid receptor in a defective human glucocorticoid receptor. Journal of Biological Chemistry 273 24439-24447.
26. Gronemeyer H, Gustafsson JA & Laudet V 2004 Principles for modulation of the nuclear receptor superfamily. Nature Reviews. Drug Discovery 3 950-964.
27. Grossmann C & Gekle M 2007 Non-classical actions of the mineralocorticoid receptor: misuse of EGF receptors? Molecular and Cellular Endocrinology 277 6-12.
28. Grossmann C, Freudinger R, Mildenberger S, Husse B & Gekle M 2008 EF domains are sufficient for nongenomic mineralocorticoid receptor actions. Journal of Biological Chemistry 283 7109-7116.
29. He B, Kemppainen JA, Voegel JJ, Gronemeyer H & Wilson EM 1999 Activation function 2 in the human androgen receptor ligand binding domain mediates interdomain communication with the NH(2)-terminal domain. Journal of Biological Chemistry 274 37219-37225.
30. He B, Minges JT, Lee LW & Wilson EM 2002 The FXXLF motif mediates androgen receptor - specific interactions with coregulators. Journal of Biological Chemistry 277 10226-10235.
31. Hellal-Levy C, Fagart J, Souque A, Wurtz J-M, Moras D & Rafestin-Oblin M-E 2000 Crucial role of the H11-H12 loop in stabilizing the active conformation of the human mineralocorticoid receptor. Molecular Endocrinology 14 1210-1221.
32. Hultman ML, Krasnoperova NV, Li S, Du S, Xia C, Dietz JD, Lala DS, Welsch DJ & Hu X 2005 The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms. Molecular Endocrinology 19 1460-1473.
33. Iniguez-Lluhi JA & Pearce D 2000 A common motif within the negative regulatory regions of multiple factors inhibits their transcriptional synergy. Molecular and Cellular Biology 20 6040-6050.
34. Kemppainen JA, Langley E, Wong CI, Bobseine K, Kelce WR & Wilson EM 1999 Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone. Molecular Endocrinology 13 440-454.
35. Kitagawa H, Yanagisawa J, Fuse H, Ogawa S, Yogiashi Y, Okuno A, Nagasawa H, Nakajima T, Matsumoto T & Kato S 2002 Ligand-selective potentiation of rat mineralocorticoid receptor activation function 1 by a CBP-containing histone acetyltransferase complex. Molecular and Cellular Biology 22 3698-3706.
36. De Kloet ER, Vreugdenhil E, Oitzl MS & Joels M 1998 Brain corticosteroid receptor balance in health and disease. Endocrine Reviews 19 269-301.
37. Knutti D & Kralli A 2001 PGC-1, a versatile coactivator. Trends in Endocrinology and Metabolism 12 360-365.
38. Kolla V & Litwack G 2000 Inhibition of mineralocorticoid-mediated transcription by NF-κB. Archives of Biochemistry and Biophysics 383 38-45.
39. Krust A, Kastner P, Petkovich M, Zelent A & Chambon P 1989 A third human retinoic acid receptor, hRAR-gamma. PNAS 86 5310-5314.
40. Kuningas M, de Rijk RH, Westendorp RG, Jolles J, Slagboom PE & van Heemst D 2007 Mental performance in old age dependent on cortisol and genetic variance in the mineralocorticoid and glucocorticoid receptors. Neuropsychopharmacology 32 1295-1301.
41. Kwak SP, Patel PD, Thompson RC, Akil H & Watson SJ 1993 5′-Heterogeneity of the mineralocorticoid receptor messenger ribonucleic acid: differential expression and regulation of splice variants within the rat hippocampus. Endocrinology 133 2344-2350.
42. Lavery DN & McEwan IJ 2005 Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations. Biochemical Journal 391 449-464.
43. Li Y, Suino K, Daugherty J & Xu HE 2005 Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Molecular Cell 19 367-380.
44. Lim-Tio SS, Keightley M-C & Fuller PJ 1997 Determinants of specificity of transactivation by the mineralocorticoid or glucocorticoid receptor. Endocrinology 138 2537-2543.
45. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR & Sigler PB 1991 Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352 497-505.
46. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M & Chambon P 1995 The nuclear receptor superfamily: the second decade. Cell 83 835-839.
47. Matias PM, Donner P, Coelho R, Thomaz M, Peixoto C, Macedo S, Otto N, Joschko S, Scholz P & Wegg A 2000 Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations. Journal of Biological Chemistry 275 26164-26171.
48. McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR & O'Malley BW 1987 Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235 1214-1217.
49. McEwan I, Lavery D, Fischer K & Watt K 2007 Natural disordered sequences in the amino terminal domain of nuclear receptors: lessons from the androgen and glucocorticoid receptors. Nuclear Receptor Signaling 5 e001.
50. Metivier K, Petit FG, Valotaire Y & Pakdel F 2000 Function of N-terminal transactivation domain of the estrogen receptor requires a potential alpha-helical structure and is negatively regulated by the A domain. Molecular Endocrinology 14 1849-1871.
51. Metivier R, Stark A, Flouriot G, Hubner MR, Brand H, Penot G, Manu D, Denger S, Reid G & Kos M 2002 A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains. Molecular Cell 10 1019-1032.
52. Mihailidou AS, Mardini M & Funder JW 2004 Rapid, nongenomic effects of aldosterone in the heart mediated by epsilon protein kinase C. Endocrinology 145 773-780.
53. Morrison N, Harrap SB & Arriza JL 1990 Regional chromosomal assignment of the human mineralocorticoid receptor gene to 4q31.1. Human Genetics 85 130-132.
54. Obradovic D, Tirard M, Nmethy Zs, Hirsch O, Gronemeyer H & Almeida OFX 2004 DAXX, FLASH, and FAF-1 modulate mineralocorticoid and glucocorticoid receptor-mediated transcription in hippocampal cells-toward a basis for the opposite actions elicited by two nuclear receptors? Molecular Pharmacology 65 761-769.
55. Ortlund EA, Bridgham JT, Redinbo MR & Thornton JW 2007 Crystal structure of an ancient protein: evolution by conformational epistasis. Science 317 1544-1548.
56. Pascual G & Glass CK 2006 Nuclear receptors versus inflammation: mechanisms of transrepression. Trends in Endocrinology and Metabolism 17 321-327.
57. Pascual-Le Tallec L & Lombes M 2005 The mineralocorticoid receptor: a journey exploring its diversity and specificity of action. Molecular Endocrinology 19 2211-2221.
58. Pascual-Le Tallec L, Kirsh O, Lecomte MC, Viengchareun S, Zennaro MC, Dejean A & Lombes M 2003 Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. Molecular Endocrinology 17 2529-2542.
59. Pearce D & Yamamoto KR 1993 Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259 1161-1165.
60. Petkovich M, Brand NJ, Krust A & Chambon P 1987 A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 330 444-450.
61. Pitt B 2004 Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the PALES and EPHESUS studies. Molecular and Cellular Endocrinology 217 53-58.
62. Rafestin-Oblin ME, Souque A, Bocchi B, Pinon G, Fagart J & Vandewalle A 2003 The severe form of hypertension caused by the activating S810L mutation in the mineralocorticoid receptor is cortisone related. Endocrinology 144 528-533.
63. Robin-Jagerschmidt C, Wurtz JM, Guillot B, Gofflo D, Benhamou B, Vergezac A, Ossart C, Moras D & Philibert D 2000 Residues in the ligand binding domain that confer progestin or glucocorticoid specificity and modulate the receptor transactivation capacity. Molecular Endocrinology 14 1028-1037.
64. Rogerson FM & Fuller PJ 2003 Interdomain interactions in the mineralocorticoid receptor. Molecular and Cellular Endocrinology 200 45-55.
65. Rogerson FM, Dimopoulos N, Sluka P, Chu S, Curtis AJ & Fuller PJ 1999 Structural determinants of aldosterone binding selectivity in the mineralocorticoid receptor. Journal of Biological Chemistry 274 36305-36311.
66. Rupprecht R, Arriza JL, Spengler D, Reul JM, Evans RM, Holsboer F & Damm K 1993 Transactivation and synergistic properties of the mineralocorticoid receptor: relationship to the glucocorticoid receptor. Molecular Endocrinology 7 597-603.
67. Schaufele F, Carbonell X, Guerbadot M, Borngraeber S, Chapman MS, Ma AAK, Miner JN & Diamond MI 2005 The structural basis of androgen receptor activation: intramolecular and intermolecular amino-carboxy interactions. PNAS 102 9802-9807.
68. Shiau AK, Barstad D, Loria PM, Cheng L, Kushner PJ, Agard DA & Greene GL 1998 The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 95 927-937.
69. Stanley TB, Leesnitzer LM, Montana VG, Galardi CM, Lambert MH, Holt JA, Xu HE, Moore LB, Blanchard SG & Stimmel JB 2003 Subtype specific effects of peroxisome proliferator-activated receptor ligands on corepressor affinity. Biochemistry 42 9278-9287.
70. Stewart PM & Mason JI 1995 Cortisol to cortisone: glucocorticoid to mineralocorticoid. Steroids 60 143-146.
71. Struthers AD 2004 Aldosterone in heart failure: pathophysiology and treatment. Current Heart Failure Reports 1 171-175.
72. Sturm A, Bury N, Dengreville L, Fagart J, Flouriot G, Rafestin-Oblin ME & Prunet P 2005 11-Deoxycorticosterone is a potent agonist of the rainbow trout (Oncorhynchus mykiss) mineralocorticoid receptor. Endocrinology 146 47-55.
73. Takeda Y, Yoneda T, Demura M, Miyamori I & Mabuchi H 2000 Cardiac aldosterone production in genetically hypertensive rats. Hypertension 36 495-500.
74. Tetel MJ, Giangrande PH, Leonhardt SA, McDonnell DP & Edwards DP 1999 Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. Molecular Endocrinology 13 910-924.
75. Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L & Lombs M 2007 The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nuclear Receptor Signaling 5 e012.
76. Vivat V, Gofflo D, Garcia T, Wurtz JM, Bourguet W, Philibert D & Gronemeyer H 1997 Sequences in the ligand-binding domains of the human androgen and progesterone receptors which determine their distinct ligand identities. Journal of Molecular Endocrinology 18 147-160.
77. Wehling M, Eisen C & Christ M 1992 Aldosterone-specific membrane receptors and rapid non-genomic actions of mineralocorticoids. Molecular and Cellular Endocrinology 90 C5-C9.
78. Weinberger C, Hollenberg SM, Ong ES, Harmon JM, Brower ST, Cidlowski J, Thompson EB, Rosenfeld MG & Evans RM 1985 Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 228 740-743.
79. White PC, Mune T & Agarwal AK 1997 11β-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocrine Reviews 18 135-156.
80. Williams SP & Sigler PB 1998 Atomic structure of progesterone complexed with its receptor. Nature 393 392-396.
81. Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT et al. 2002 Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha. Nature 415 813-817.
82. Yokota K, Shibata H, Kurihara I, Kobayashi S, Suda N, Murai-Takeda A, Saito I, Kitagawa H, Kato S & Saruta T 2007 Coactivation of the N-terminal transactivation of mineralocorticoid receptor by Ubc9. Journal of Biological Chemistry 282 1998-2010.
83. Zennaro M-C, Keightley M-C, Kotelevtsev Y, Conway GS, Soubrier F & Fuller PJ 1995 Human mineralocorticoid receptor genomic structure and identification of expressed isoforms. Journal of Biological Chemistry 270 21016-21020.
84. Zhang J, Tsai FTF & Geller DS 2006 Differential interaction of RU486 with the progesterone and glucocorticoid receptors. Journal of Molecular Endocrinology 37 163-173.